Wei Shi, MD, PhD, is a dedicated oncology and rare diseases clinical development professional with extensive experience in managing clinical development for solid tumors and hematologic malignancies. Having held senior roles at BioMarin Pharmaceutical Inc., Covance, and Amgen, they have specialized in clinical development and strategic planning within the oncology field. Currently, Wei is focused on clinical development and innovation at Ipsen, while also pursuing a PhD in Life Science at Uppsala University and an MD in Clinical Medicine at TongJi Medical College of HUST.
This person is not in the org chart
This person is not in any teams
This person is not in any offices